These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake. Venteicher B, Merklin K, Ngo HX, Chien HC, Hutchinson K, Campbell J, Way H, Griffith J, Alvarado C, Chandra S, Hill E, Schlessinger A, Thomas AA. ChemMedChem; 2021 Mar 03; 16(5):869-880. PubMed ID: 33230949 [Abstract] [Full Text] [Related]
43. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O. Biochem Pharmacol; 2005 Nov 25; 70(11):1673-84. PubMed ID: 16213467 [Abstract] [Full Text] [Related]
46. Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants. Zhu HJ, Markowitz JS. Drug Metab Dispos; 2009 Feb 25; 37(2):264-7. PubMed ID: 19022936 [Abstract] [Full Text] [Related]
47. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro. Siccardi D, Gumbleton M, Omidi Y, McGuigan C. Eur J Pharm Sci; 2004 May 25; 22(1):25-31. PubMed ID: 15113580 [Abstract] [Full Text] [Related]
48. Oligoethylene ester derivatives of ketoprofen, naproxen and diclofenac as oral prodrugs: a pharmacological evaluation. Bonina F, Puglia C, Santagati NA, Saija A, Tomaino A, Tita B. Pharmazie; 2002 Aug 25; 57(8):552-5. PubMed ID: 12227196 [Abstract] [Full Text] [Related]
51. Large neutral amino acid transporter enables brain drug delivery via prodrugs. Gynther M, Laine K, Ropponen J, Leppänen J, Mannila A, Nevalainen T, Savolainen J, Järvinen T, Rautio J. J Med Chem; 2008 Feb 28; 51(4):932-6. PubMed ID: 18217702 [Abstract] [Full Text] [Related]
52. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Danks MK, Morton CL, Krull EJ, Cheshire PJ, Richmond LB, Naeve CW, Pawlik CA, Houghton PJ, Potter PM. Clin Cancer Res; 1999 Apr 28; 5(4):917-24. PubMed ID: 10213229 [Abstract] [Full Text] [Related]
53. Analysis of metabolite kinetics by deconvolution and in vivo-in vitro correlations of metabolite formation rates: studies of fibrinogen receptor antagonist ester prodrugs. Prueksaritanont T, Gorham LM, Yeh KC. J Pharm Sci; 1997 Dec 28; 86(12):1345-51. PubMed ID: 9423143 [Abstract] [Full Text] [Related]
54. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity. Aboul-Fadl T, Al-Hamad SS, Fouad EA. Bioorg Chem; 2018 Feb 28; 76():370-379. PubMed ID: 29241109 [Abstract] [Full Text] [Related]
57. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies. Prueksaritanont T, Gorham LM, Ellis JD, Fernandez-Metzler C, Deluna P, Gehret JR, Strong KL, Hochman JH, Askew BC, Duggan ME, Gilbert JD, Lin JH, Vyas KP. Drug Metab Dispos; 1996 Nov 28; 24(11):1263-71. PubMed ID: 8937862 [Abstract] [Full Text] [Related]
58. The physicochemical properties, in vitro metabolism and pharmacokinetics of a novel ester prodrug of EXP3174. Yan YD, Kim HK, Seo KH, Lee WS, Lee GS, Woo JS, Yong CS, Choi HG. Mol Pharm; 2010 Dec 06; 7(6):2132-40. PubMed ID: 20849146 [Abstract] [Full Text] [Related]
59. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung. Gabriele M, Puccini P, Lucchi M, Vizziello A, Gervasi PG, Longo V. Biochem Pharmacol; 2018 Apr 06; 150():64-71. PubMed ID: 29407485 [Abstract] [Full Text] [Related]
60. Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection. Li J, Liu S, Shi J, Zhu HJ. Pharmaceutics; 2021 Oct 11; 13(10):. PubMed ID: 34683949 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]